# INNOVATE Corp.: overview

VATE · NYSE · CIK 1006837 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/vate.md) · [Financials](/companies/vate/financials.md) · [Filings](/companies/vate/filings.md) · [Insiders](/companies/vate/insiders.md)

Latest reported revenue: [$421.6m](/filings/0001006837-26-000063.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 6, 2026 (XBRL us-gaap:Revenues, accession 0001006837-26-000063).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [242](/filings/0001006837-24-000155.md) | [237 d](/filings/0001006837-26-000014.md) | [274](/filings/0001006837-26-000039.md) | [242](/filings/0001006837-26-000063.md) | [347](/filings/0001006837-25-000127.md) | [383 d](/filings/0001006837-26-000014.md) | [365](/filings/0001006837-26-000039.md) | [422](/filings/0001006837-26-000063.md) |
| Gross margin | % | [19.9%](/filings/0001006837-25-000127.md) | [19.6% d](/filings/0001006837-26-000014.md) | [16.6%](/filings/0001006837-26-000039.md) | [18.8%](/filings/0001006837-26-000063.md) | [14.3%](/filings/0001006837-25-000127.md) | [15.4% d](/filings/0001006837-26-000014.md) | [14.7%](/filings/0001006837-26-000039.md) | [18.9%](/filings/0001006837-26-000063.md) |
| Operating margin | % | [2.4%](/filings/0001006837-25-000127.md) | [1.1% d](/filings/0001006837-26-000014.md) | [1.2%](/filings/0001006837-26-000039.md) | [2.0%](/filings/0001006837-26-000063.md) | [1.8%](/filings/0001006837-25-000127.md) | [3.7% d](/filings/0001006837-26-000014.md) | [2.7%](/filings/0001006837-26-000039.md) | [8.2%](/filings/0001006837-26-000063.md) |
| Net margin | % | [(6.2%)](/filings/0001006837-25-000127.md) | [(7.0%) d](/filings/0001006837-26-000014.md) | [(8.9%)](/filings/0001006837-26-000039.md) | [(8.2%)](/filings/0001006837-26-000063.md) | [(2.6%)](/filings/0001006837-25-000127.md) | [(1.9%) d](/filings/0001006837-26-000014.md) | [(4.6%)](/filings/0001006837-26-000039.md) | [2.5%](/filings/0001006837-26-000063.md) |
| Diluted EPS | $ per share | [(1.18)](/filings/0001006837-25-000127.md) | not reported | [(1.89)](/filings/0001006837-26-000039.md) | [(1.67)](/filings/0001006837-26-000063.md) | [(0.71)](/filings/0001006837-25-000127.md) | not reported | [(1.29)](/filings/0001006837-26-000039.md) | [0.71](/filings/0001006837-26-000063.md) |
| Free cash flow | $m | [(31.5) d](/filings/0001006837-25-000127.md) | [34.2 d](/filings/0001006837-26-000014.md) | [(18.8)](/filings/0001006837-26-000039.md) | [36.0 d](/filings/0001006837-26-000063.md) | [19.0 d](/filings/0001006837-25-000127.md) | [101 d](/filings/0001006837-26-000014.md) | [45.3](/filings/0001006837-26-000039.md) | [(24.7) d](/filings/0001006837-26-000063.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,205](/filings/0001006837-23-000018.md) | [1,637](/filings/0001006837-24-000023.md) | [1,423](/filings/0001006837-24-000023.md) | [1,107](/filings/0001006837-26-000014.md) | [1,246](/filings/0001006837-26-000014.md) |
| Gross margin | % | [15.2%](/filings/0001006837-23-000018.md) | [13.5%](/filings/0001006837-24-000023.md) | [15.2%](/filings/0001006837-25-000021.md) | [18.9%](/filings/0001006837-26-000014.md) | [16.0%](/filings/0001006837-26-000014.md) |
| Operating margin | % | [(0.9%)](/filings/0001006837-23-000018.md) | [0.8%](/filings/0001006837-24-000023.md) | [1.9%](/filings/0001006837-25-000021.md) | [3.6%](/filings/0001006837-26-000014.md) | [2.3%](/filings/0001006837-26-000014.md) |
| Net margin | % | [(18.9%)](/filings/0001006837-23-000018.md) | [(2.2%)](/filings/0001006837-24-000023.md) | [(2.5%)](/filings/0001006837-25-000021.md) | [(3.1%)](/filings/0001006837-26-000014.md) | [(4.9%)](/filings/0001006837-26-000014.md) |
| Diluted EPS | $ per share | [(2.98)](/filings/0001006837-23-000018.md) | [(0.53)](/filings/0001006837-24-000023.md) | [(4.81)](/filings/0001006837-25-000021.md) | [(3.08)](/filings/0001006837-26-000014.md) | [(4.84)](/filings/0001006837-26-000014.md) |
| Free cash flow | $m | [2.9](/filings/0001006837-23-000018.md) | [(30.2)](/filings/0001006837-24-000023.md) | [8.1](/filings/0001006837-25-000021.md) | [(9.9)](/filings/0001006837-26-000014.md) | [146](/filings/0001006837-26-000014.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/vate/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [Whitefort Capital Management, LP](/funds/1884931.md) | 2026-06-30 | $13.9m | 743,000 |  | Unchanged |
| [Jefferies Financial Group Inc.](/funds/96223.md) | 2026-06-30 | $13.1m | 700,802 |  | Unchanged |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $6.6m | 354,408 |  | Added +263,360 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $4.3m | 228,667 |  | Added +4,511 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $2.4m | 128,530 |  | Added +38,594 |
| [Arena Capital Advisors, LLC- CA](/funds/1833078.md) | 2026-06-30 | $2.4m | 127,934 |  | Unchanged |
| [Prescott Group Capital Management, L.L.C.](/funds/1166152.md) | 2026-06-30 | $2.0m | 109,448 |  | Unchanged |
| [MARSHALL WACE, LLP](/funds/1318757.md) | 2026-06-30 | $2.0m | 108,147 |  | New +108,147 |
| [BANK OF AMERICA CORP /DE/](/funds/70858.md) | 2026-06-30 | $1.6m | 83,239 |  | Added +67,105 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $1.5m | 82,764 |  | Added +35,000 |

## Recent filings

[All 1,313 filings](/companies/vate/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-09 | 20:15 ET | [8-K](/filings/0001006837-26-000121.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001006837-26-000121 |
| 2026-10-05 | 12:31 ET | [8-K](/filings/0001006837-26-000118.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.01 Completion of an acquisition or disposition; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001006837-26-000118 |
| 2026-09-02 | 20:18 ET | [8-K](/filings/0001006837-26-000110.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001006837-26-000110 |
| 2026-08-18 | 12:12 ET | [8-K](/filings/0001006837-26-000090.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001006837-26-000090 |
| 2026-08-14 | 20:37 ET | [SCHEDULE 13D](/filings/0001621020-26-000003.md) | Ownership report, active investor | 0001621020-26-000003 |
| 2026-08-10 | 12:26 ET | [8-K](/filings/0001006837-26-000076.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001006837-26-000076 |
| 2026-08-06 | 20:22 ET | [10-Q](/filings/0001006837-26-000063.md) | Quarterly report, period 2026-06-30 | 0001006837-26-000063 |
| 2026-08-06 | 20:13 ET | [8-K](/filings/0001006837-26-000061.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001006837-26-000061 |
| 2026-08-03 | 12:28 ET | [8-K](/filings/0001006837-26-000053.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001006837-26-000053 |
| 2026-07-08 | 20:14 ET | [8-K](/filings/0001006837-26-000051.md) | 8.01 Other events | 0001006837-26-000051 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001006837-26-000014.md), filed Mar 26, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/fd354e5e-9c77-42b7-a646-8cf1930fcab9)

## About the filer

- CIK: 1006837
- Tickers: VATE
- Exchange: NYSE
- SIC code: 3440 Fabricated Structural Metal Products
- State of incorporation: DE
- Filer category: Non-accelerated filer<br>Smaller reporting company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:30 ET. No prices; not investment advice.
